Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease / G. F. Makhaeva, N. V. Kovaleva, E. V. Rudakova [et al.] // Frontiers in Pharmacology. – 2023. – Vol. 14.